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SCIENTIFIC EDITORIAL
Hospital management of heart failure: improvement 
but still room for improvement at discharge…
Prise en charge hospitalière d’une insuffisance cardiaque :
du mieux, mais encore du travail à faire après…
A. Cohen-Solal*
Département de cardiologie, Groupe hospitalier universitaire Lariboisière (AP-HP), Paris.
How to manage heart failure in the hospital setting is
already a major issue and is likely to become even more so
in the future. The prevalence of heart disease is ever rising
while the number of hospital beds regularly drops, and the
medium-term predictions of the capacity of our hospital
system to cope with this problem are fairly pessimistic [1].
In principle, the ideal destination for these patients is a
cardiology department and a number of studies have shown
that heart patients' chances of survival are lower if they are
admitted into other departments, especially internal medi-
cine. However, for many of them, their age and the long
stay necessary do not seem to be conducive to their admis-
sion into a specialised cardiology department compared
with other patients who could benefit from a shorter stay —
the average length of stay in France is ten days as opposed
to just four in the United States [2] — or a treatment moda-
lity that is more economically "advantageous" for the hospi-
tal. Heart failure nevertheless represents one of the main
reasons for hospital admission. For the Paris emergency
(SMUR), it is the leading reason for calls, way ahead of coro-
nary heart disease. If these patients reach the hospital's
emergency room, the problem of referral arises: internal
medicine or cardiology. The advantages of admission into a
specialised department are greater medical expertise and
the capacity for the repetition of special additional exami-
nations which are indispensable and crucial for diagnosis
and treatment, such as Doppler ultrasonography or natriu-
retic peptide assays.
In addition, many studies point to the importance of the-
rapeutic patient education [3, 4] and outpatient care [5, 6]
in these patients if the number of re-admissions is to be cut
down and prognosis improved. However, such patient edu-
cation is rarely undertaken in today's context in which redu-
cing stay length is an ongoing priority.
It is vital to try to adhere to learned societies' guidelines
on how to treat heart failure due to impaired left ventricu-
lar systolic function [7], protocols which are now well defi-
ned. A number of studies have shown that failure to follow
these guidelines compromises outcome [8]. Nevertheless,
quadruple therapy is not always easy to administer in
elderly patients with several co-morbidities [9]. As short
hospital stays usually follow an episode of destabilisation,
such stays are not the most conducive to the introduction of
certain new drugs like beta-blockers [10] and often make it
difficult to obtain the ideal recommended dosages. For this
reason, the hospital stay must be followed up with outpa-
tient care or treatment by a private practitioner, the exact
details of which are yet to be defined, but which should
take into account the fact that heart failure is a chronic
disease that warrants constant drug and dosage adjust-
ment. 
This issue of Archives of Cardiovascular Diseases [11]
includes a report on a survey conducted by the staff at the
cardiology department of the Hôpital des Instructions des
Armées de Bégin concerning the care they provide for
patients with heart failure. Such self-evaluation of medical
practice in the treatment of heart failure is rare. Most sur-
veys — usually conducted at the behest of the authorities —
focus on costlier conditions such as coronary heart disease,
so this is a welcome initiative. The records of all patients
admitted for heart failure in the first six months of 2005
were evaluated. It is worth noting that ultrasonography was
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carried out in 77% of patients in the cardiology department
although, unfortunately, we do not know the interval
between admission and the performance of this examina-
tion. This, however, is an important parameter since we
know that the earlier the ultrasound examination is perfor-
med, the better-matched will be the treatment. It is diffi-
cult to imagine prescribing the same treatment to a patient
with global heart failure with a LVEF of 20% against a bac-
kground of primary dilated cardiomyopathy, and one with
Grade 3 functional mitral insufficiency; or to someone with
paroxystic left ventricular failure with episodic hyperten-
sion and preserved systolic function, and a patient with
tight aortic narrowing (which is silent as a result of the low
flow rate). The value of natriuretic peptide assays has often
been questioned because of their cost and insufficient sen-
sitivity and specificity. It is good to see that, in this survey,
at least one assay (NT pro BNP) was performed in all
patients. We know that interpreting the results of these
assays is not always easy in the elderly or obese or in
patients with kidney failure, especially after a long hospital
stay. Ideally, this assay should be performed on admission
in order to provide the best possible aid in diagnosis [12]
and again just before discharge to revise the prognosis and
enable dosage adjustment. It is known that a post-dis-
charge BNP concentration of over 800 pg/ml is associated
with a higher risk of re-admission or death within six
months (more than 75% higher) [12]. However, at present,
repeating this assay during the stay does not seem to be
warranted.
Analysis of the recruited population shows that 63% of
the patients had impaired left ventricular systolic function,
and this proportion rises to 80% in the sub-population of
patients over 75; this suggests skewed recruiting [11] since,
in most studies, a left ventricular ejection fraction of over
45% is seen in more than 50% of over-75 year-olds [9]. 
In therapeutic terms, the picture is fairly good with most
of the patients receiving the recommended drugs — in par-
ticular, 68% of those with impaired left ventricular systolic
function having been prescribed a licensed beta-blocker,
and 32% of the same group having been prescribed spirono-
lactone [11]. It would have been interesting to be told the
dosages of these products at the end of the hospital stay in
order to make it possible to estimate the work that remains
to be done after discharge, until the ideal recommended
dosage is established. Prognosis remains relatively grim in
these patients with 35% re-admitted and a hospital morta-
lity of 13%, figures that are consistent with previously
published findings [2, 7].
The authors emphasise the importance of diet and the
education dispensed in the course of the hospital stay to
about half of the patients with a reduced LVEF. They can be
congratulated for this effort which is far from being syste-
matic in all cardiology departments. Nevertheless, it is
important to recognise that hospitalisation for acute heart
failure is difficult to reconcile with optimum patient educa-
tion, and that ongoing education is absolutely essential.
Finally, it is a pity that only 7% of patients with impaired
left ventricular systolic function were given rehabilitation,
whereas current guidelines recommend it for most subjects
with NYHA Class II, III or IV disease [7]. It is therefore impor-
tant that such self-evaluations be carried out on a regular
basis to review the efficacy of hospital-based care and
identify where there may be room for improvement, with
subsequent follow-up playing an almost indispensable role,
either in the context of a care network [13] or accompanied
by outpatient cardiac rehabilitation [14].
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